This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Celgene Corp (CELG)

NASDAQ: Health Care

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 7.67B 6.49B 5.51B 4.84B
Cost of Sales 270.60M 229.10M 210.18M 352.23M
Gross Operating Profit 7.40B 6.26B 5.30B 4.49B
Selling, General, and Administrative Expenses 2.03B 1.68B 1.37B 1.23B
Research & Development 2.43B 2.23B 1.72B 1.60B
Operating Income before D & A (EBITDA) 2.94B 2.35B 2.20B 1.66B
Depreciation & Amortization 373.60M 374.10M 283.45M 362.85M
Interest Income 28.20M 0.00 15.26M 25.86M
Other Income - Net -92.40M -223.00M -17.01M -3.55M
Special Income / Charges 48.70M 171.10M -168.95M 284.69M
Total Income Before Interest Expenses (EBIT) 2.50B 1.76B 1.74B 1.46B
Interest Expense 176.10M 91.60M 63.20M 42.74M
Pre-Tax Income 2.33B 1.67B 1.68B 1.42B
Income Taxes 327.50M 215.50M 225.31M 102.07M
Minority Interest 0.00 0.00 0.00 -694.00K
Net Income From Continuing Operations 2.00B 1.45B 1.46B 1.32B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 2.00B 1.45B 1.46B 1.32B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 2.00B 1.45B 1.46B 1.32B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.00B 1.45B 1.63B 1.18B
Preferred Dividends
Net Income Available To Common 2.00B 1.45B 1.46B 1.32B
Basic EPS from Continuing Ops. 2.49 1.75 1.69 1.45
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.49 1.75 1.69 1.45
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.49 1.75 1.69 1.45
Basic Normalized Net Income/Share 2.49 1.75 1.89 1.29
EPS fr Continuing Ops. 2.39 1.68 1.65 1.42
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.39 1.68 1.65 1.42
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.39 1.69 1.65 1.43
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.39 1.68 1.84 1.27
Dividends Paid per Share 0.00 0.00 0.00 0.00
CELG News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for CELG

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 13 12 13 12
Moderate Buy 1 1 1 1
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CELG ANALYST REPORT

CELG Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs